companydata.dkSerprozyme ApS: Financial statements 2025
CVR: 44083205
Serprozyme ApS (CVR 44083205) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 168,506 and a net result of DKK 131,445 compared with DKK 24,507 the year before. That is an increase of 443% compared with the year before. Equity amounted to DKK 193,766. The solvency ratio was 84%.
- Gross Profit
- 168,506 kr.
- Profit/Loss
- 131,445 kr.
- Equity
- 193,766 kr.
- Total Assets
- 230,726 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 169 t. | 131 t. | 194 t. | 0 |
| 2024 | - | 31 t. | 25 t. | 62 t. | 0 |
Find more companies like Serprozyme ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Serprozyme ApS has published its annual report for 2024. Gross profit came to DKK 31,033, and the net result was DKK 24,507.
About Serprozyme ApS
Serprozyme ApS is a Danish company of the type Anpartsselskab based in Randers SV, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kristian Jensen. The company is owned by Emvijo Initiative ApS and Jan Kristian Jensen Holding ApS. In 2025, the company reported a gross profit of DKK 168,506 and a net result of DKK 131,445 compared with DKK 24,507 the year before. Equity amounted to DKK 193,766.